SORT1 and hyperlipidemia: Upon activation, this axis maintains activation of miR- 378a-3p biogenesis, suppression of Sort1, increased stabilization and secretion of ApoB100, which subsequently facilitates hepatic secretion of VLDL and aggravates the pathogenesis of hyperlipidemia and hypolipoproteinemia.